Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Biotech
Lilly early Alzheimer's data shows amyloid drop, ARIA side effect
Lilly’s up-and-coming Alzheimer’s treatment remternetug resulted in “rapid and robust” plaque clearance but also ran into a familiar adverse event.
Annalee Armstrong
Mar 31, 2023 11:01am
Top 10 pharma R&D budgets in 2022
Mar 27, 2023 3:00am
Galapagos, following Sanofi’s playbook, offloads R&D site to CRO
Mar 31, 2023 8:30am
Molecular Templates halves headcount as cash crunch looms
Mar 31, 2023 6:30am
David Liu’s lab finds base editing may spur one-time SMA therapy
Mar 31, 2023 2:46pm
Cytokinetics’ pipeline tumble persists after ALS med flops
Mar 31, 2023 11:03am
MedTech News
FDA begins investigation of unauthorized dental device
Mar 31, 2023 10:32am
Abbott nets FDA green light for surgical heart valve replacement
Mar 31, 2023 9:59am
Phenomix debuts saliva test for first of 4 types of obesity
Mar 30, 2023 5:10pm
Bigfoot Biomedical picks up auto-adjusting insulin algorithm
Mar 30, 2023 1:14pm
See More MedTech News